Skip to content
Aminoscope
The desk

Research

Evidence reviews across peptides, GLP-1 medications, and longevity therapeutics. No secondary summaries — every claim traced to the trial, the label, or the paper of record.

placebo −2.4%−14.9%MEAN BODY-WEIGHT CHANGE · 68 WEEKS
GLP-1

What the semaglutide weight-loss trials actually showed

STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

6 min read